Foundation programme
Introduction to Peptides in Health and Disease
Clinical foundations and evidence-based reasoning
The intellectual framework that underpins all clinical education within the Institute. Rather than focusing on individual compounds, participants learn how experienced clinicians evaluate emerging therapies when the evidence is evolving.
About this programme
This introductory programme establishes the reasoning, governance and evidence-appraisal framework used throughout the Institute's clinical curriculum. It is deliberately compound-agnostic — its purpose is to train clinicians how to think about emerging therapies, not what to prescribe.
Learning objectives
- Map the current evidence landscape for therapeutic peptides.
- Apply structured tools to critically appraise different study designs.
- Reason transparently under conditions of evolving evidence.
- Recognise governance and safety principles relevant to emerging therapies.
- Communicate uncertainty to patients in a way that supports informed consent.
- Identify the regulatory boundaries that apply in U.S. clinical practice.
Programme outline
- Understanding the peptide evidence landscape
- Critical appraisal of different levels of evidence
- Clinical reasoning under uncertainty
- Patient safety and governance principles
- Evidence communication and informed consent
- Regulatory considerations within the United States (FDA, DEA, state boards)
Format
Online modular learning with structured assessment.
Audience
An introduction for practitioners wishing to understand the field before progressing to individual clinical domains.
Prerequisites
Registered healthcare professional or equivalent background.
Dates & pricing
Enrolment dates, fees and admissions criteria will be published in due course. To register interest, please use the enquiry form on the home page.